Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

被引：0
|
作者：
Umesh Gangishetti
J. Christina Howell
Richard J. Perrin
Natalia Louneva
Kelly D. Watts
Alexander Kollhoff
Murray Grossman
David A. Wolk
Leslie M. Shaw
John C. Morris
John Q. Trojanowski
Anne M. Fagan
Steven E. Arnold
William T. Hu
机构：
[1] Emory University,Department of Neurology
[2] Emory University,Department of Alzheimer’s Disease Research Center
[3] Washington University,Knight Alzheimer’s Disease Research Center
[4] Washington University,Department of Pathology
[5] Washington University,Department of Neurology
[6] University of Pennsylvania,Penn Memory Center
[7] University of Pennsylvania,Center for Neurodegenerative Disease Research
[8] University of Pennsylvania,Penn FTD Center
[9] University of Pennsylvania,Department of Neurology
[10] University of Pennsylvania,Department of Pathology and Laboratory Medicine
[11] Present Address: Massachusetts General Hospital,undefined
来源：
Alzheimer's Research & Therapy | / 10卷
关键词：
Biomarkers; Fatty acid binding protein; Interleukin-10; Mild cognitive impairment; Neurofilament light chain;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease
    Gangishetti, Umesh
    Howell, J. Christina
    Perrin, Richard J.
    Louneva, Natalia
    Watts, Kelly D.
    Kollhoff, Alexander
    Grossman, Murray
    Wolk, David A.
    Shaw, Leslie M.
    Morris, John C.
    Trojanowski, John Q.
    Fagan, Anne M.
    Arnold, Steven E.
    Hu, William T.
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [2] CSF non-Beta-Amyloid, non-Tau Biomarkers for Clinical Alzheimer's Disease Stages
    Gangishetti, Umesh
    Howell, J. Christina
    Perrin, Richard
    Morris, John
    Trojanowski, John
    Fagan, Anne
    Arnold, Steven
    Hu, William
    NEUROLOGY, 2018, 90
  • [3] Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease
    Mandic, Gorana
    Markovic, Ivanka
    Ostojic, Marija
    Stojkovic, Tanja
    Misirlic-Dencic, Sonja
    Zivanovic-Radnic, Tatjana
    Stefanovic, Rodoljub
    Bumbasirevic, Marko
    Stefanova, Elka
    Kostic, Vladimir
    VOJNOSANITETSKI PREGLED, 2008, 65 (12) : 901 - 905
  • [4] Evaluation of Cerebrospinal Fluid Tau/Beta-Amyloid(42) Ratio as Diagnostic Markers for Alzheimer Disease
    Smach, Mohamed Ali
    Charfeddine, Bassem
    Othman, Leila Ben
    Lammouchi, Turkia
    Dridi, Hedi
    Nafati, Souhir
    Ltaief, Afef
    Bennamou, Soufien
    Limem, Khalifa
    EUROPEAN NEUROLOGY, 2009, 62 (06) : 349 - 355
  • [5] Concentrations of Metals, β-Amyloid and Tau-Markers in Cerebrospinal Fluid in Patients with Alzheimer's Disease
    Gerhardsson, Lars
    Blennow, Kaj
    Lundh, Thomas
    Londos, Elisabet
    Minthon, Lennart
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (01) : 88 - 94
  • [6] Tau and amyloid β protein in cerebrospinal fluid as biomarkers of Alzheimer's disease
    Kanai, M
    Harigaya, Y
    Kawarabayashi, T
    Ikeda, M
    Okamoto, K
    Shoji, M
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S380 - S380
  • [7] Brain Metabolic Correlates of Cerebrospinal Fluid Beta-Amyloid 42 and Tau in Alzheimer's Disease
    Vukovich, Ruth
    Perneczky, Robert
    Drzezga, Alexander
    Foerstl, Hans
    Kurz, Alexander
    Riemenschneider, Matthias
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 27 (05) : 474 - 480
  • [8] Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease
    Mielke, Michelle M.
    Haughey, Norman J.
    Bandaru, Veera. V. R.
    Zetterberg, Henrik
    Blennowd, Kaj
    Andreasson, Ulf
    Johnson, Sterling C.
    Gleason, Carey E.
    Blazel, Hanna M.
    Puglielli, Luigi
    Sager, Mark A.
    Asthana, Sanjay
    Carlsson, Cynthia M.
    NEUROBIOLOGY OF AGING, 2014, 35 (11) : 2486 - 2494
  • [9] Cerebrospinal fluid β-amyloid and tau proteins for the diagnosis of Alzheimer disease
    Knopman, D
    ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 349 - 350
  • [10] Amyloid beta 1–42 and tau in the cerebrospinal fluid of renal failure patients for the diagnosis of Alzheimer′s disease
    Yat Fung Shea
    Leung-wing Chu
    Ming-yee Maggie Mok
    Man-Fai Lam
    Journal of Nephrology, 2014, 27 : 217 - 220
12345